llewin, Author at PRECISIONvalue

White Paper: Achieving Launch Excellence: A Novel Data- and Analytics-Informed Approach

Data and analytics can help drive and inform launch preparations and support efforts to achieve launch excellence through realistic goal-setting and risk mitigation. PRECISIONadvisors works with manufacturers, helping them make key decisions—related to product positioning, go-to-market strategy, and customer engagement across payers, providers, prescribers, and patients—through data- and analytics-driven insights. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.

LEARN MORE

White Paper: Achieving Launch Excellence: A Novel Data- and Analytics-Informed Approachllewin2023-05-10T15:51:38-04:00

Collaboration is Needed Among Stakeholders for Genetic Tests to be Beneficial

More and more genetic tests are coming onto the market to help make sure the right patient gets the right drug at the right time. However, the sheer volume of these tests may be overwhelming payers in their coverage decisions. Precision’s Erin Lopata and others weigh in on the need for shareholders to work together to help establish the clinical utility that payers need to make coverage decisions on genetic tests.

LEARN MORE

Collaboration is Needed Among Stakeholders for Genetic Tests to be Beneficialllewin2023-01-19T09:23:27-05:00

40 Under 40: Isabella Sergio

We're excited to announce that two of our Precision colleagues have been named to MM+M's 40 Under 40 this year! Congratulations to Ashwin Athri, EVP, Managing Director, PRECISIONxtract, and Isabella Sergio, EVP, Managing Director, PRECISIONvalue. Now in its fourth year, 40 Under 40 honors the industry’s best-regarded young talent. We look forward to celebrating with Ashwin and Isabella, and all the other honorees, on February 16.

LEARN MORE

40 Under 40: Isabella Sergiollewin2023-02-20T21:32:45-05:00

Social Determinants of Health (SDOH): Threee Trends to Watch in 2023

The healthcare sector is hastening adoption of population health approaches, including initiatives to improve outcomes by closing health disparity gaps. Precision's Maureen Hennessey, Ph.D., Jorge Font, Dominic Galante, M.D., Kris Kang, and Cynthia Miller, M.D. identify three trends to watch in 2023 to tackle pernicious social determinants of health challenges.

LEARN MORE

Social Determinants of Health (SDOH): Threee Trends to Watch in 2023llewin2023-01-19T06:47:41-05:00

Early Access vs. Proven Efficacy: FDA’s Accelerated Approval Process

As Congress moves to improve the accelerated approval process through the Accelerated Approval Integrity Act, we must understand its history and ways to mitigate unnecessary spending while maintaining access to innovative treatments. Precision's Cynthia Miller warns of potential unintended consequences as Congress moves to improve the accelerated approval process.

LEARN MORE

Early Access vs. Proven Efficacy: FDA’s Accelerated Approval Processllewin2023-01-18T18:08:18-05:00

Digital Reshaping of the Diabetes Health-Care Ecosystem

Precision's Dr. Dominic Galante will moderate the Quality Conversations Breakfast session on Day 2 of the NCQA Health Innovation Summit. "Digital Reshaping of the Diabetes Health-Care Ecosystem" will explore the promise of leveraging patient-generated data from CGMs to improve diabetes care, health equity, and the potential to augment diabetes quality measures that are reported and tracked by quality organizations. November 1 at 7:30AM ET.

LEARN MORE

Digital Reshaping of the Diabetes Health-Care Ecosystemllewin2023-03-08T09:46:55-05:00

On-Demand Webinar – Trends in Oncology: US Payer Management Considerations for 2022 and Beyond

In the last five years, 83 novel oncology substances have launched - oncology PMPM spend is now the highest among medical benefit categories, with 105% growth anticipated by 2024. As these numbers suggest, oncology is a key area of focus for payers, who are willing to invest resources to support appropriate utilization, but who struggle to keep up with the rapidly evolving science.

LEARN MORE

On-Demand Webinar – Trends in Oncology: US Payer Management Considerations for 2022 and Beyondllewin2023-03-08T13:36:45-05:00

On-Demand Webinar – A Novel Data and Analytics-Informed Approach to Launch Excellence

Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.

LEARN MORE

On-Demand Webinar – A Novel Data and Analytics-Informed Approach to Launch Excellencellewin2023-03-08T09:44:51-05:00

Download Now: Precision November Events Calendar

Check out our November Events Calendar, and stay up to date with all of the upcoming and on-demand Precision events and thought leadership!

LEARN MORE

Download Now: Precision November Events Calendarllewin2023-02-21T15:48:01-05:00

It Takes a Village: How Pharma Can Help Address the Mental Health and Substance Abuse Crisis

Changes in climate and extreme weather affect every stakeholder in the healthcare system, not just the physicians on the front lines. Precision's Cynthia Miller suggests we need a patient focused strategy to manage environmental risk and offers solutions that align with incentives.

LEARN MORE

It Takes a Village: How Pharma Can Help Address the Mental Health and Substance Abuse Crisisllewin2022-11-09T18:26:08-05:00

About llewin